Effects of bezafibrate and simvastatin on plasma lipoproteins in hypercholesterolemia resistant to hormone replacement therapy
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Estrogen and Progestin Compared with Simvastatin for Hypercholesterolemia in Postmenopausal WomenNew England Journal of Medicine, 1997
- Plasma lipoprotein levels as predictors of cardiovascular death in womenArchives of internal medicine (1960), 1993
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- SimvastatinDrugs, 1990
- Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemiaAtherosclerosis, 1988
- BezafibrateDrugs, 1987
- Menopause and the Risk of Coronary Heart Disease in WomenNew England Journal of Medicine, 1987
- A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart DiseaseNew England Journal of Medicine, 1985
- Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjectsAtherosclerosis, 1982